References

Alcazar, J.L. (2006). Tumor angiogenesis assessed by three-dimensional power Doppler ultrasound in early, advanced and metastatic ovarian cancer: a preliminary study. Ultrasound in obstetrics & gynecology, 28(3), 325-329.

Bagri, A., et al. (2010). Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale. Trends in molecular medicine, 16(3), 122-132.

Babes, L., et al. (1999). Synthesis of iron oxide nanoparticles used as MRI contrast agents: a parametric study. Journal of colloid and interface science, 212(2), 474-482.

Bloch, S.H., P. Dayton, and K.W. Ferrara. (2004). Targeted imaging using ultrasound contrast agents. Engineering in Medicine and Biology Magazine, IEEE, 23(5), 18-29.

Cai, W. and X. Chen. (2006). Multimodality imaging of vascular endothelial growth factor and vascular endothelial growth factor receptor expression. Frontiers in bioscience: a journal and virtual library, 12, 4267-4279.

Cosgrove, D. (2014). Angiogenesis imaging–ultrasound. The British journal of radiology.

Cheung, A.M., et al. (2007). Detecting vascular changes in tumour xenografts using micro-ultrasound and micro-CT following treatment with VEGFR-2 blocking antibodies. Ultrasound in medicine & biology, 33(8), 1259-1268.

Carmeliet, P. and R.K. Jain,. (2000). Angiogenesis in cancer and other diseases. nature,  407(6801), 249-257.

Chi, A.S., et al. (2009). Angiogenesis as a therapeutic target in malignant gliomas. The oncologist,  14(6), 621-636.

Drevs, J., et al. (2000). Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model. Cancer Research, 60(17), 4819-4824.

Dewitte, H., et al. (2011). The use of ultrasound contrast agents in cancer immunotherapy: The use of mRNA-loaded microbubbles for transfection of dendritic cells. Parallel HOW TO session.

Duda, D.G., et al. (2007). VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects. Trends in molecular medicine, 13(6), 223-230.

Ferrara, N. (2004). Vascular endothelial growth factor: basic science and clinical progress. Endocrine reviews, 25(4), 581-611.

Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature medicine, 1(1), 27-30.

Forsberg, F., et al. (2004). Assessment of angiogenesis: implications for ultrasound imaging. Ultrasonics, 42(1), 325-330.

Forsberg, F., et al. (2002). Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary results. Ultrasound in medicine & biology, 28(4), 445-451.

Fujii, H., et al. (2013). Optimization of ultrasound-mediated anti-angiogenic cancer gene therapy. Molecular Therapy—Nucleic Acids, 2(5),  e94.

Grothey, A. and E. Galanis. (2009). Targeting angiogenesis: progress with anti-VEGF treatment with large molecules. Nature reviews Clinical oncology, 6(9), 507-518.

Hicklin, D.J. and L.M. Ellis. (2005). Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. Journal of clinical oncology,  23(5), 1011-1027.

Halpern, E.J. and S.E. Strup. (2000). Using gray-scale and color and power Doppler sonography to detect prostatic cancer. American Journal of Roentgenology, 174(3), 623-627.

Hata, K., et al. (1998). Expression of thymidine phosphorylase in malignant ovarian tumors: correlation with microvessel density and an ultrasound-derived index of angiogenesis. Ultrasound in obstetrics & gynecology, 12(3), 201-206.

Kwok, S.J., et al. (2013). Ultrasound-mediated microbubble enhancement of radiation therapy studied using three-dimensional high-frequency power doppler ultrasound. Ultrasound in medicine & biology, 39(11), 1983-1990.

Kadambi, A., et al. (2001). Vascular Endothelial Growth Factor (VEGF)-C Differentially Affects Tumor Vascular Function and Leukocyte Recruitment Role of VEGF-Receptor 2 and Host VEGF-A. Cancer research, 61(6), 2404-2408.

Korpanty, G., et al. (2007). Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clinical Cancer Research, 13(1), 323-330.

Kittel, C., P. McEuen, and P. McEuen. (1976). Introduction to solid state physics. Vol. 8, Wiley New York.

Korpanty, G., et al. (2005). Targeting vascular endothelium with avidin microbubbles. Ultrasound in medicine & biology, 31(9), 1279-1283.
Korpanty, G., et al. (2005). Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles. Gene therapy, 12(17), 1305-1312.

Leong-Poi, H. (2009). Molecular imaging using contrast-enhanced ultrasound: evaluation of angiogenesis and cell therapy. Cardiovascular research, 84(2), 190-200.

Liang, H. and M. Blomley. (2014). The role of ultrasound in molecular imaging. The British journal of radiology.

Massoud, T.F. and S.S. Gambhir. (2003). Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes & development, 17(5), 545-580.

Prewett, M., et al. (1999). Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer research, 59(20), 5209-5218.

Selleck, S.B. (2006). Signaling from across the way: transactivation of VEGF receptors by HSPGs. Molecular cell, 22(4), 431-432.
Sun, J., et al. (2005). Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors. Oncogene, 24(29), 4701-4709.

Shohet, R.V., et al. (2000). Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation, 101(22), 2554-2556.

Tsuzuki, Y., et al. (2000). Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1α→ hypoxia response element→ VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer research, 60(22), 6248-6252.

Tortora, G., F. Ciardiello, and G. Gasparini. (2008). Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications. Nature Clinical Practice Oncology, 5(9), 521-530.

Turkbey, B., et al. (2009). Imaging of tumor angiogenesis: functional or targeted? AJR. American journal of roentgenology, 193(2), 304.
Watanabe, H., et al. (2004). Anti-vascular endothelial growth factor receptor-2 (Flk-1/KDR) antibody suppresses contact hypersensitivity. Experimental dermatology, 13(11),  671-681.

Wink, M.H., et al. (2006). Ultrasound imaging and contrast agents: A safe alternative to MRI? Minimally Invasive Therapy & Allied Technologies, 15(2), 93-100.

Willmann, J.r.K., et al. (2008). US Imaging of Tumor Angiogenesis with Microbubbles Targeted to Vascular Endothelial Growth Factor Receptor Type 2 in Mice 1. Radiology, 246(2), 508-518.

Yang, W.T., et al. (2002). Correlation between color power Doppler sonographic measurement of breast tumor vasculature and immunohistochemical analysis of microvessel density for the quantitation of angiogenesis. Journal of ultrasound in medicine, 21(11), 1227-1235.

Young, S. and M. Dyson. (1990). The effect of therapeutic ultrasound on angiogenesis. Ultrasound in medicine & biology, 16(3), 261-269.

Zhu, A.X., et al. (2011). HCC and angiogenesis: possible targets and future directions. Nature reviews Clinical oncology, 8(5), 292-301.